UC vs. CD diagnosis, age, sex, anti-TNF use, thiopurine use, 5-ASA use and being seen by a gastroenterologist in the 5 years to 6 months prior to CRC diagnosis did not impact survival among individuals with IBD-CRC. This evidence concerns the gene TNF and colorectal carcinoma.